Peptron
ISIN KR7087010005
|WKN A1406E
Market cap (in EUR)
3,452 m
Country
South Korea
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. Its products include medicines for prostate cancer, hyperpituitarism, diabetes, degenerative neuronal disease, and obesity, peptide materials, and cosmetics. The company was founded on November 21, 1997 and is headquartered in Daejeon, South Korea.
Healthcare Healthcare Services Miscellaneous Healthcare South Korea
Financials
Key metrics
| Market capitalisation, EUR | 3,452 m |
| EPS, EUR | -0.40 |
| P/B ratio | 40.4 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2024)
| Revenue, EUR | 2 m |
| Net income, EUR | -15 m |
| Profit margin | -699.00% |
What ETF is Peptron in?
There are 4 ETFs which contain Peptron. All of these ETFs are listed in the table below. The ETF with the largest weighting of Peptron is the iShares MSCI Emerging Markets Small Cap UCITS ETF.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| iShares MSCI Emerging Markets Small Cap UCITS ETF | 0.34% | Equity Emerging Markets Small Cap | 302 |
| Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing | 0.06% | Equity Asia Pacific Social/Environmental | 26 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 496 |
| iShares MSCI EM IMI Screened UCITS ETF USD (Dist) | 0.05% | Equity Emerging Markets Social/Environmental | 1,185 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.